Systemic inflammatory response syndrome in patients with liver cirrhosis

Arab Journal of Gastroenterology

Volumn 12, Issue 4, 2011, Pages 173-177

  Abdel Khalek, Ehab E ^a   El Fakhry, Ashraf ^a   Helaly, Mohamed ^a   Hamed, Magdy ^a   Elbaz, Osama ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Child Pugh score; Hepatorenal syndrome; Inflammatory response syndrome; Liver cirrhosis; Portal hypertension

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; BILIRUBIN; CREATININE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; BACTERIAL INFECTION; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; HEPATIC ENCEPHALOPATHY; HOSPITALIZATION; HUMAN; JAUNDICE; LEUKOCYTE COUNT; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PORTAL HYPERTENSION; PREVALENCE; PRIORITY JOURNAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADULT; ALANINE TRANSAMINASE; BACTERIAL INFECTIONS; BILIRUBIN; CREATININE; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOGLOBINS; HEPATIC ENCEPHALOPATHY; HEPATORENAL SYNDROME; HOSPITAL MORTALITY; HUMANS; HYPERTENSION, PORTAL; INTERNATIONAL NORMALIZED RATIO; JAUNDICE; LENGTH OF STAY; LEUKOCYTE COUNT; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; SERUM ALBUMIN; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84856535429     PISSN: 16871979     EISSN: 20902387     Source Type: Journal    
DOI: 10.1016/j.ajg.2011.11.006     Document Type: Article

References (27)

1. Merli M., Lucidi C., Giannelli V., Giusto M., Riggio O., Falcone M., Ridola L., Attili A.F., Venditti M. Cirrhotic patients are at risk for health care-associated bacterial infections. Clin Gastroenterol Hepatol 2010, 8(11):979-985.
2. Thabut D., Massard J., Gangloff A., Carbonell N., Francoz C., Nguyen-Khac E., et al. Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure. Hepatology 2007, 46:1872-1882.
3. Tandon B., Garcia-Tsao G. Bacterial infection, sepsis, and multiorgan failure in cirrhosis. Sem Liver Dis 2008, 28:26-42.
4. Arvaniti V., D'Amico G., Fede G., Manousou P., Tsochatzis E., Pleguezuelo M., Burroughs A.K. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology 2010, 139(4):1246-1256.
5. Plessier A., Dennenger M.-H., Consigny Y., Pessione F., Francoz C., Durand F., et al. Coagulation disorders in patients with cirrhosis and severe sepsis. Liver Int 2003, 23:440-448.
6. Amitrano L., Guardascione M.A., Brancaccio V., Balzano A. Coagulation disorders in liver disease. Sem Liver Dis 2002, 22:83-96.
7. Altorjay I., Vitalis Z., Tornai I., Palatka K., Kacska S., Farkas G., Udvardy M., Harsfalvi J., Dinya T., Orosz P., Lombay B., Par G., Par A., Csak T., Osztovits J., Szalay F., Csepregi A., Lakatos P.L., Papp M. Mannose-binding lectin deficiency confers risk for bacterial infections in a large Hungarian cohort of patients with liver cirrhosis. Hepatology 2010, 53(3):484-491.
8. Lach L., Gines P., Arroyo V., Rimola A., Tito L., Badalamenti S., et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology 1988, 94:482-487.
9. du Cheyron D., Bouchet B., Parienti J.J., Ramakers M., Charbonneau P. The attributable mortality of acute renal failure in critically ill patients with liver cirrhosis. Intensive Care Med 2005, 31(12):1693-1699.
10. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Chest 1992, 101:1644-1655.
11. Rimola A., Garcia-Tsao G., Navasa M., Piddock L.J., Planas R., Bernard B., et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol 2000, 32:142-153.
12. Sobel J.D., Kaye D. Urinary tract infections. Principles and Practice of Infectious Diseases 1995, Churchill Livingstone, New York, 662-690. 4th ed. G.L. Mandell, J.E. Bennet, R. Dolin (Eds.).
13. Fasolato S., Angeli P., Dallagnese L., Maresio G., Zola E., Mazza E., et al. Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features. Hepatology 2007, 45:223-229.
14. Pugh R.N.H., Murray-Lyon I.M., Dawson J.L., Pietroni M.C., Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973, 60:646-649.
15. Salerno F., Gerbes A., Gines P., Wong F., Arroyo V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 2007, 56:1310-1318.
16. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005, 43(1):167-176.
17. Atterbury C.E., Maddrey W.C., Conn H.O. Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial. Am J Dig Dis 1978, 23(5):398-406.
18. Munor B.H., Jacobsen B.S., Duffy M.E., Bratmar L.E. Statistical Methods for Health Care Research 2002, University of Pennsilvania, Boston College, Lipincott, pp. 1-412.
19. Kalambokis G., Tsianos E.V. Endotoxaemia in the pathogenesis of cytopenias in liver cirrhosis. Could oral antibiotics raise blood counts?. Med Hypotheses 2011, 76(1):105-109.
20. Bolognesi M., Merkel C., Bianco S., Angeli P., Sacerdoti D., Amodio P., et al. Clinical significance of the evaluation of the hepatic reticuloendothelial removal capacity in patients with cirrhosis. Hepatology 1994, 19:628-634.
21. Wilkinson S.P., Arroyo V., Gazzard B.G., Monodie H., Williams R. Relation of renal impairment and hemorrhagic diathesis to endotoxemia in fulminant hepatic failure. Lancet 1974, 1:521-524.
22. Cirera I., Bauer T.M., Navasa M., Vila J., Grande L., Taura P., et al. Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol 2001, 34:32-37.
23. Cazzaniga M., Dionigi E., Gobbo G., Fioretti A., Monti V., Salerno F. The systemic inflammatory response syndrome in cirrhotic patients: relations with their in-hospital outcome. J Hepatol 2009, 51(3):475-482.
24. Navasa M., Follo A., Filella X., Jimenez W., Francitorra A., Planas R., et al. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal failure and mortality. Hepatology 1998, 27:1227-1232.
25. Sort P., Navasa M., Arroyo V., Aldeguer X., Planas R., Ruiz-del-Arbol L., et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999, 341:403-409.
26. Goulis J., Patch D., Burroughs A.K. Bacterial infection in the pathogenesis of variceal bleeding. Lancet 1999, 353:139-142.
27. Afessa B., Kubilis P.S. Upper gastrointestinal bleeding in patients with hepatic cirrhosis: clinical course and mortality prediction. Am J Gastroenterol 2000, 95:484-489.